Clinical Trial Update: An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer [Phase 2]

View source ↗

Summary

Open-label, multicenter Phase II trial of Dovitinib in advanced thyroid cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Dovitinib (dovitinib)

Snippet

Sponsor: Yonsei University | Conditions: Thyroid Cancer | Phase 2 | Status: COMPLETED